DDAH1 and schizophrenia: Compared to healthy controls, reduced nitrergic neurons, NOS activity, dysregulation in the enzymes regulating the bioavalibility of L-arginine, dimethylarginine dimethylaminohydrolase 1 (DDAH1) and arginase have been observed in schizophrenia patients [19–22].